JPMorgan Chase & Co. boosted its holdings in shares of Belite Bio, Inc (NASDAQ:BLTE – Free Report) by 7,122.7% in the 3rd ...

Koreas biotech firms strive for growth amid investment challenges at JP Morgan event K-Bio executives highlight new strategies to adapt in a challenging investment landscape at a major healthcare gath ...

K-Bio leaders pursue U.S. factories and conferences during Lunar New Year K-Bio executives opt for international business ...

Upstream Bio (NASDAQ:UPB – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Thursday, February 6th. Analysts expect Upstream Bio to post earnings of ...

Tevogen Bio Holdings Inc. (“Company” or“Tevogen Bio”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.Cho0xxI9.js ...

JPMorgan Chase, Citi, Bank of America, U.S. Bank and Wells Fargo postpone payments for damaged or destroyed homes.

The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...

CFO Aradhana Sarin outlined AstraZeneca’s plans at the 2025 JP Morgan Healthcare Conference ... potential acquisition agreement with SixPeaks Bio, announced in May 2024.

The Apprentice star, who owns a large portfolio of central London office buildings, made the comments in a BBC interview.

The British architect has built an unprecedented factory of fine design. Inside the world of the man who creates exquisite ...

Meanwhile, LOTTE BIOLOGICS' Syracuse Bio Campus received a flawless quality evaluation last year, with no findings reported during inspections by Japan's Pharmaceuticals and Medical Devices Agency ...